T2 Biosystems Sponsored Presentation: Breaking New Ground in Sepsis Diagnosis and Management with Non-Culture-Based Tests
Session Recording Description:
This sponsored session will discuss how the T2 Biosystems use of non-culture-based tests (NCTs) provide faster and more accurate results than the current standard of care that relies upon culture-based testing. T2 Biosystems’ Panels provide results directly from a whole blood sample, often before the second dose of antibiotics is delivered. Dr. Aparna Ahuja will discuss the impact of sepsis on healthcare costs and patient outcomes as well as reviewing the growing challenge of antimicrobial resistance. Dr. Debbie Goff will discuss the critical importance of time to appropriate therapy in sepsis patients and how non culture based tests can improve patient outcomes. Attendees will gain insight on the current challenges in sepsis diagnosis and management and how improvements can be made with non-culture based tests. Sepsis survivor case studies will be shared.
Industry leaders, Public Policy Experts, Health and hospital Leadership (C-Suite, physicians, nurses, pharmacists, CIOs), Health quality and decision support leaders, Health Investors and VCs, Health and Technology Media, Health Advocates, Health Advisors, Health Educators, Health Marketers.
Debra Goff, PharmD, FCCP
Professor of Pharmacy Practice, Infectious Disease Specialist, The Ohio State University Wexner Medical Center
Dr. Goff is an Infectious Disease Specialist pharmacist, global antibiotic stewardship expert and founding member of the Antimicrobial Stewardship Program (ASP) at The Ohio State University (OSU) Wexner Medical Center (OSUWMC) and Professor of Pharmacy Practice in the College of Pharmacy in Columbus Ohio USA. She received the 2019 OSU Distinguished International Outreach and Engagement Award for her ongoing work in South Africa and hospitals across six continents. Dr. Goff is one of twenty-five global experts selected by the World Health Organization (WHO) to implement stewardship programs in low-middle income countries (LMIC).
Aparna Ahuja, MD
Chief Medical Officer, T2 Biosystems
No continuing education credits are offered for this session.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.